Examining the Efficacy of Personalized Lifestyle Intervention in Individuals With Rheumatoid Arthritis
Launched by HACETTEPE UNIVERSITY · Mar 7, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a personalized lifestyle intervention can improve the daily lives of people with rheumatoid arthritis (RA). Researchers want to see if tailored lifestyle changes can help with work performance, overall health, and quality of life for individuals living with this condition. The trial is currently recruiting participants aged 18 to 65 who have been diagnosed with RA and have low to moderate disease activity. To join, individuals should not have made any changes to their RA medications in the last three months or had any surgeries in the past six months.
Participants in this trial can expect to engage in a program designed specifically for their needs, focusing on lifestyle adjustments that could positively impact their health and well-being. It's important to know that individuals with other serious health issues, such as other musculoskeletal or neurological diseases, or those who are pregnant, are not eligible to participate. This trial could be a valuable opportunity for those looking to enhance their quality of life through personalized approaches.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Being diagnosed with RA between the ages of 18-65 and meeting the ACR/EULAR diagnostic criteria
- • Patients with low to moderate disease activity (DAS28 ≤5.1)
- • No pharmacological treatment changes for RA in the last 3 months
- • Have not had any surgery in the last 6 months
- • Understand and cooperate with testing guidelines
- • to be literate
- Exclusion Criteria:
- • Having any musculoskeletal disease, neurological disease, and/or visual and auditory impairment other than RA
- • Pregnancy
About Hacettepe University
Hacettepe University is a leading research institution in Turkey, renowned for its commitment to advancing medical science and healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, the university supports a wide range of clinical trials aimed at improving patient outcomes and developing new therapeutic approaches. Hacettepe University is dedicated to maintaining the highest ethical standards and regulatory compliance in its research endeavors, fostering an environment that promotes scientific excellence and contributes to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Mani̇sa, , Turkey
Patients applied
Trial Officials
TIMUR PIRILDAR, PROF
Study Director
Manisa Celal Bayar University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials